MDPCX
Price
$14.84
Change
-$0.02 (-0.13%)
Updated
Jul 18 closing price
Net Assets
78.32M
VEMRX
Price
$106.00
Change
+$0.10 (+0.09%)
Updated
Jul 18 closing price
Net Assets
124.04B
Interact to see
Advertisement

MDPCX vs VEMRX

Header iconMDPCX vs VEMRX Comparison
Open Charts MDPCX vs VEMRXBanner chart's image
BlackRock Sustainable Em Mkts Eq Inv A
Price$14.84
Change-$0.02 (-0.13%)
VolumeN/A
Net Assets78.32M
Vanguard Emerging Mkts Stock Idx InsPlus
Price$106.00
Change+$0.10 (+0.09%)
VolumeN/A
Net Assets124.04B
MDPCX vs VEMRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MDPCX vs. VEMRX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDPCX is a Buy and VEMRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMRX has more cash in the bank: 124B vs. MDPCX (78.3M). VEMRX pays higher dividends than MDPCX: VEMRX (2.81) vs MDPCX (2.14). MDPCX was incepted earlier than VEMRX: MDPCX (31 years) vs VEMRX (15 years). MDPCX (1.48) is less costly to investors than VEMRX (0.07). MDPCX is a more actively managed with annual turnover of: 47.00 vs. VEMRX (8.00). MDPCX has a lower initial minimum investment than VEMRX: MDPCX (1000) vs VEMRX (100000000). MDPCX (15.08) and VEMRX (14.84) have marching annual gain over last year. VEMRX return over 5 years is better than : 30.91 vs. MDPCX (-1.33).
MDPCXVEMRXMDPCX / VEMRX
Total Expense Ratio1.110.071,586%
Annual Report Gross Expense Ratio1.480.072,114%
Fund Existence31 years15 years-
Gain YTD16.87914.162119%
Front Load5%N/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets78.3M124B0%
Annual Yield % from dividends2.142.8176%
Returns for 1 year15.0814.84102%
Returns for 3 years34.7834.00102%
Returns for 5 years-1.3330.91-4%
Returns for 10 years-9.5650.04-19%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZNTL1.440.05
+3.60%
Zentalis Pharmaceuticals
IBRX2.830.08
+2.91%
ImmunityBio
BON1.460.02
+1.39%
Bon Natural Life Limited
BWMN32.490.33
+1.03%
Bowman Consulting Group Ltd
TOL116.74N/A
N/A
Toll Brothers